Guardant Price To Sales Ratio from 2010 to 2024
| GH Stock | USD 35.61 0.51 1.45% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 5.37155092 | Current Value 5.1 | Quarterly Volatility 37.08664206 |
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Tax Provision of 719.2 K, Net Interest Income of 34.4 M or Interest Income of 37.1 M, as well as many indicators such as Price To Sales Ratio of 5.1, Dividend Yield of 0.0022 or PTB Ratio of 13.78. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
Guardant | Price To Sales Ratio |
Latest Guardant Health's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Guardant Health over the last few years. Price to Sales Ratio is figured by comparing Guardant Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Guardant Health sales, a figure that is much harder to manipulate than other Guardant Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Guardant Health's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardant Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.36 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Guardant Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 54.01 | |
| Geometric Mean | 35.59 | |
| Coefficient Of Variation | 68.66 | |
| Mean Deviation | 33.76 | |
| Median | 45.69 | |
| Standard Deviation | 37.09 | |
| Sample Variance | 1,375 | |
| Range | 85.084 | |
| R-Value | (0.91) | |
| Mean Square Error | 260.78 | |
| R-Squared | 0.82 | |
| Slope | (7.53) | |
| Total Sum of Squares | 19,256 |
Guardant Price To Sales Ratio History
About Guardant Health Financial Statements
Investors use fundamental indicators, such as Guardant Health's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Guardant Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 5.37 | 5.10 |
Currently Active Assets on Macroaxis
Check out the analysis of Guardant Health Correlation against competitors. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.